Albaconazole

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAlbaconazole
Drug Alias Namealbaconazolum阿巴康唑albaconazolealbaconazolUR-9825 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 51 inhibitors
TargetsCytochrome P450 51
Therapy Area/IndicationsTinea PedisOnychomycosisCandidiasis, Vulvovaginal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[4
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPalau PharmaUriach
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsTinea PedisOnychomycosisCandidiasis, Vulvovaginal

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG